Immupharma Share Discussion Threads

[alphorn] 07/5/2019 12:30

Shuffling the chairs about?

[newtothisgame3] 07/5/2019 12:05

ImmuPharma Exploring European Listing For Combined French Businesses (ALLIPO) LONDON (Alliance News) - ImmuPharma PLC is exploring the merger and possible separate listing of ...
Alliance News7 May, 2019 | 11:06AM

[newtothisgame3] 07/5/2019 12:05

ImmuPharma Exploring European Listing For Combined French Businesses (ALLIPO) LONDON (Alliance News) - ImmuPharma PLC is exploring the merger and possible separate listing of ...
Alliance News7 May, 2019 | 11:06AM

[kirk 6] 07/5/2019 10:41

Exciting times ahead

[wigwammer] 07/5/2019 10:35

If today's update was a negative signal for the future of lupuzor, then this is an odd thing for management to conclude: "This in turn would allow ImmuPharma PLC to focus on Lupuzor(TM) and the overall P140 platform for different auto-immune indications. Further details will be announced in due course."

[kirk 6] 07/5/2019 09:30

Who is Andrew?

[glennrcharles] 07/5/2019 08:40

Of course it could be that they know the results of the extension and they either don't need the emap or they have the possibility to finance another phase 3 trial

[borromini1] 07/5/2019 08:28

RNS 1934Y
Doesn’t provide the level of detail to change the current share price.

IMM have not explicitly stated that regulatory authorities have given approvel for the MAP to proceed, while using the establishment of a pre-agreed final route to market scenario as the reason for suspension of the MAP process.

The Open Label Extension still offers up no indication of the outcome, but surely the results can’t be delayed beyond the end of June or after the AGM.

Rearranging the assets for sale on a European market is trying another tack after the Incanthera failure. The Final Results for 2018 due this month will presumably confirm that £2m of IMM funds are now locked into Incanthera.

Tim’s role as chairman and fund raiser now seems diminished.

[youngharry2] 07/5/2019 07:48

Andrew, your non stop bile and vitriol is a little tiresome. Have a good long look at your self and try to grow up.

[nobbygnome] 07/5/2019 07:34

And there you have it. The EMAP program has been stopped without saying why. Looks like the cash is running out to me with no sale or deal to bale them out.

Perhaps a good way to save money would be for lyin Tim to leave and save the company his fees....

[glennrcharles] 07/5/2019 07:34

So they are hoping to fund a new trial with the sale?

[newtothisgame3] 05/5/2019 21:33

Incorporate best practices into your EMAPs strategy and broaden the scope of current programmes with expert insight from J&J & #ImmuPharma #IMM

[newtothisgame3] 05/5/2019 21:33

Incorporate best practices into your EMAPs strategy and broaden the scope of current programmes with expert insight from J&J & ImmuPharma IMM

[newtothisgame3] 05/5/2019 21:28

Dimitri Dimitriou, CEO, Immupharma

[newtothisgame3] 05/5/2019 21:28

Dimitri Dimitriou, CEO, Immupharma

[newtothisgame3] 05/5/2019 21:24

LSX World Congress formerly known as Biotech and Money Congress
133 Houndsditch | Liverpool St | London
4-5 February, 2020

Meet our 2019 speakers Dimitri Dimitriou, CEO, Immupharma
…

[newtothisgame3] 05/5/2019 21:23

LSX World Congress formerly known as Biotech and Money Congress
133 Houndsditch | Liverpool St | London
4-5 February, 2020

Meet our 2019 speakers Dimitri Dimitriou, CEO, Immupharma
…

[kop202] 02/5/2019 13:56

Too crooks spoil the broth

[ken chung] 30/4/2019 23:28

Lemmings and mushrooms only now.

[kop202] 29/4/2019 12:40

Ken.... your too generous

[ken chung] 25/4/2019 19:06

8p coming.

[kop202] 25/4/2019 13:30

Kirk....in your dreamsToo many people shafted first time round